These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33974284)

  • 1. Prodromal sensory neuropathy in Pink1
    Valek L; Tran B; Wilken-Schmitz A; Trautmann S; Heidler J; Schmid T; Brüne B; Thomas D; Deller T; Geisslinger G; Auburger G; Tegeder I
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1060-1079. PubMed ID: 33974284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression.
    Gispert S; Brehm N; Weil J; Seidel K; Rüb U; Kern B; Walter M; Roeper J; Auburger G
    Hum Mol Genet; 2015 Feb; 24(4):1061-76. PubMed ID: 25296918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of pathology in PINK1-deficient mouse brain from splicing via ubiquitination, ER stress, and mitophagy changes to neuroinflammation.
    Torres-Odio S; Key J; Hoepken HH; Canet-Pons J; Valek L; Roller B; Walter M; Morales-Gordo B; Meierhofer D; Harter PN; Mittelbronn M; Tegeder I; Gispert S; Auburger G
    J Neuroinflammation; 2017 Aug; 14(1):154. PubMed ID: 28768533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
    Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
    J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.
    Marongiu R; Spencer B; Crews L; Adame A; Patrick C; Trejo M; Dallapiccola B; Valente EM; Masliah E
    J Neurochem; 2009 Mar; 108(6):1561-74. PubMed ID: 19166511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
    Chen L; Xie Z; Turkson S; Zhuang X
    J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease
    Yoon HH; Ye S; Lim S; Jo A; Lee H; Hong F; Lee SE; Oh SJ; Kim NR; Kim K; Kim BJ; Kim H; Lee CJ; Nam MH; Hur JW; Jeon SR
    CRISPR J; 2022 Feb; 5(1):95-108. PubMed ID: 35191750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course.
    Tayebi N; Parisiadou L; Berhe B; Gonzalez AN; Serra-Vinardell J; Tamargo RJ; Maniwang E; Sorrentino Z; Fujiwara H; Grey RJ; Hassan S; Blech-Hermoni YN; Chen C; McGlinchey R; Makariou-Pikis C; Brooks M; Ginns EI; Ory DS; Giasson BI; Sidransky E
    Mol Genet Metab; 2017 Dec; 122(4):198-208. PubMed ID: 29173981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in α-synuclein and PINK1 expression reduce neurite length and induce mitochondrial fission and Golgi fragmentation in midbrain neurons.
    Furlong RM; O'Keeffe GW; O'Neill C; Sullivan AM
    Neurosci Lett; 2020 Feb; 720():134777. PubMed ID: 31978495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
    Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
    Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
    Rothman SM; Griffioen KJ; Fishbein KW; Spencer RG; Makrogiannis S; Cong WN; Martin B; Mattson MP
    Neurobiol Aging; 2014 May; 35(5):1153-61. PubMed ID: 24239384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson's Disease.
    Portz P; Lee MK
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.
    Orr AL; Rutaganira FU; de Roulet D; Huang EJ; Hertz NT; Shokat KM; Nakamura K
    Neurochem Int; 2017 Oct; 109():106-116. PubMed ID: 28434973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration.
    Gispert S; Ricciardi F; Kurz A; Azizov M; Hoepken HH; Becker D; Voos W; Leuner K; Müller WE; Kudin AP; Kunz WS; Zimmermann A; Roeper J; Wenzel D; Jendrach M; García-Arencíbia M; Fernández-Ruiz J; Huber L; Rohrer H; Barrera M; Reichert AS; Rüb U; Chen A; Nussbaum RL; Auburger G
    PLoS One; 2009 Jun; 4(6):e5777. PubMed ID: 19492057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
    Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
    Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.